RTW INVESTMENTS, LP Q4 2020 Filing
Filed February 16, 2021
Portfolio Value
$6.0B
Holdings
102
Report Date
Q4 2020
Filing Type
13F-HR
All Holdings (102 positions)
| Stock | Value |
|---|---|
RCKTRocket Pharmaceuticals Inc | $935.6M |
IMVTImmunovant Inc | $350.7M |
PTCTPTC Therapeutics Inc | $257.7M |
MRTXEURMirati Therapeutics Inc | $231.6M |
STOKStoke Therapeutics Inc | $219.5M |
ALNYAlnylam Pharmaceuticals Inc | $218.6M |
NTRANatera Inc | $170.4M |
—Dicerna Pharmaceuticals Inc | $159.8M |
ARVNArvinas Inc | $152.1M |
VCELVericel Corp | $139.5M |
AXSMAxsome Therapeutics Inc | $136.3M |
ILMNIllumina Inc | $133.9M |
CERNCHFCerner Corp | $133.5M |
3M4Masimo Corp | $126.0M |
GMEDGlobus Med Inc | $107.0M |
RNAAvidity Biosciences Inc | $102.0M |
TARSTarsus Pharmaceuticals Inc. | $99.0M |
AXNX*Axonics Modulation Technolog | $94.0M |
DMTKQDermTech Inc | $93.7M |
TXG10x Genomics Inc | $93.6M |
—Athira Pharma Inc | $88.9M |
ESTAEstablishment Labs Hldgs Inc | $87.3M |
—Frequency Therapeutics Inc | $86.8M |
ADVMCHFAdverum Biotechnologies Inc | $78.3M |
GHGuardant Health Inc | $75.0M |
LUNGPulmonx Corp | $74.8M |
PTGXProtagonist Therapeutics Inc | $73.6M |
CCCCC4 Therapeutics Inc | $68.7M |
TNDMTandem Diabetes Care Inc | $63.2M |
TCE2Celldex Therapeutics Inc New | $60.0M |
KURAKura Oncology Inc | $55.6M |
—Translate Bio Inc | $54.9M |
NSTGEURNanoString Technologies Inc | $53.8M |
CSTLCastle Biosciences Inc | $53.7M |
RLMDRelmada Therapeutics Inc | $48.5M |
OPHTEURIVERIC bio Inc | $46.5M |
—Five Prime Therapeutics Inc | $42.8M |
CYTKCytokinetics Inc | $41.3M |
AGENEURAgenus Inc | $40.9M |
OYSTOyster Pt Pharma Inc | $36.2M |
AVDLAvadel Pharmaceuticals plc | $36.0M |
5E7Iteos Therapeutics Inc | $36.0M |
OMGBPOutset Med Inc | $33.3M |
TREURTrillium Therapeutics Inc | $31.9M |
PMVPPmv Pharmaceuticals Inc | $30.8M |
—Curis Inc | $30.5M |
BLIUSDBerkeley Lts Inc | $29.0M |
MISTMilestone Pharmaceuticals In | $28.9M |
MGNXMacroGenics Inc | $28.7M |
IDYAIdeaya Biosciences Inc | $25.9M |
MDXGMiMedx Group Inc | $24.5M |
APYXApyx Medical Corporation | $24.4M |
FULCFulcrum Therapeutics Inc | $24.3M |
JNJJohnson & Johnson | $23.6M |
I9DNArbutus Biopharma Corp | $21.2M |
PRQRProQR Thrapeutics N V | $21.0M |
TELATela Bio Inc | $20.8M |
PENPenumbra Inc | $20.7M |
—Odonate Therapeutics Inc | $19.2M |
XGNExagen Inc | $16.5M |
BLUBellus Health Inc New | $15.8M |
IMUXImmunic Inc | $14.1M |
AFIBAcutus Med Inc | $13.0M |
RGNXRegenxbio Inc | $12.8M |
—GenMark Diagnostics Inc | $11.1M |
CLSDUSDClearside Biomedical Inc | $10.8M |
APVOAptevo Therapeutics Inc | $10.6M |
—Vincera Pharma Inc | $10.5M |
CTMXCytomx Therapeutics Inc | $10.0M |
ARGXargenx SE | $9.3M |
—La Jolla Pharmaceutical Co | $9.3M |
MLTXHelix Acquisition Corp | $8.5M |
BWAYBrainsway Ltd | $8.3M |
CERE1EURCerevel Therapeutics Hldng I | $8.3M |
SRRKScholar Rock Hldg Corp | $8.1M |
—Lifesci Acquisition Ii Corp | $6.9M |
—BCTG Acquisition Corp | $6.9M |
—Bcls Acquisition Corp | $6.8M |
—Therapeutics Acquisition Cor | $6.8M |
INMDInmode Ltd | $5.9M |
—Arya Sciences Acquisition Co | $5.4M |
PSNLPersonalis Inc | $4.7M |
—Itamar Med Ltd | $4.5M |
—5 01 Acquisition Corp | $4.0M |
PHGEBiomx Inc | $3.8M |
—Panacea Acquisition Corp | $3.8M |
IMTXImmatics N.V | $3.8M |
—Chardan Healthcr Acqstn 2 Co | $3.7M |
TWSTTwist Bioscience Corp | $2.6M |
BDSXBiodesix Inc | $2.5M |
PRNProfound Med Corp | $2.5M |
MASS908 Devices Inc | $2.3M |
MRVIMaravai Lifesciences Hldgs I | $2.0M |
EP3OraSure Technologies Inc | $1.9M |
ELUTAziyo Biologics Inc | $1.7M |
—Vincera Pharma Inc | $1.6M |
—Cerevel Therapeutics Hldng I | $942K |
BNRBurning Rock Biotech Ltd | $693K |
—Progenity Inc | $531K |
PHGEBiomX Inc | $480K |
Page 1 of 2Next